New study finds 70 percent of able-bodied hockey players have abnormal hip and p...(other internal body structures. This s...),Health
Navigation Links
New study finds 70 percent of able-bodied hockey players have abnormal hip and pelvis MRIs
Date:3/13/2010
other internal body structures.
"This study raises all sorts of questions that should be examined in further studies. For example, will these abnormalities cause problems and symptoms later for these athletes?" said Silvis. "But this study shows the limitations of depending too heavily on an MRI. A surgeon may see something in the image, but it isn't causing a problem."
'/>"/>
| Contact: Lisa Weisenberger lisa@aossm.org 847-292-4900 American Orthopaedic Society for Sports Medicine Source:Eurekalert |
Related medicine news :
1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
(Date:5/22/2012)... MAYWOOD, Ill. -- Children born with cleft lip, ... medical challenges beyond appearance. , Patients can face ... well as social and psychological challenges, Laura Swibel ... colleagues write in the June 2012 issue of ... "The management of patients with craniofacial syndromes is ...
(Date:5/22/2012)... began last year when the U.S. Preventive Services Task ... prostate-cancer tests to healthy men continued this week when ... stuck to their guns, stating that a blood test ... test, causes more harm than good it leads ... , But many people simply don,t believe that the ...
(Date:5/22/2012)... HealthDay Reporter , , TUESDAY, May 22 (HealthDay News) ... with earlier development of precancerous colon lesions recommend people ... a younger age than others. "Based on our ... screenings earlier, possibly at age 40, rather than at ... fellow at Washington University in St. Louis. However, ...
(Date:5/22/2012)... (HealthDay News) -- Healthier lifestyles and better disease management ... Americans with diabetes between 1997 and 2006, especially ... federal government report shows. During that time, deaths ... 23 percent and deaths caused by heart disease and ... to the analysis of 1997-2004 National Health Interview Survey ...
(Date:5/22/2012)... Pushed to the brink of survival, the hyper-driven cells ... that has helped organisms cope with internal stresses and ... part of this system, heat shock protein 90 (HSP90) ... genetic changes and profound disturbances in normal biology that ... inhibiting HSP90 just might render breast cancer cells less ...
Breaking Medicine News(10 mins):Health News:Cleft lip/palate cause much more than cosmetic problems 2Health News:Psychological Science explains uproar over prostate-cancer screenings 2Health News:Middle-Aged Diabetics May Need Earlier Colon Checks 2Health News:Middle-Aged Diabetics May Need Earlier Colon Checks 3Health News:U.S. Sees Drop in Deaths Linked to Diabetes 2Health News:U.S. Sees Drop in Deaths Linked to Diabetes 3Health News:Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy 2Health News:Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy 3[0] Cleft lip/palate cause much more than cosmetic problems[0] Psychological Science explains uproar over prostate-cancer screenings[0] Middle-Aged Diabetics May Need Earlier Colon Checks[0] U.S. Sees Drop in Deaths Linked to Diabetes[0] Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy
... remains focused on expanding business, CHICAGO, Nov. ... writing medical malpractice insurance in Illinois despite a,Cook ... tort,reform law which placed caps on awards for ... decision to be a major player in,Illinois for ...
... YORK, November 14 On the first United ... calls on,governments to develop national policies for the ... donors worldwide to consider the need,for a diabetes ... Speaking at the World Diabetes Day press ...
... prevention programs targeting high-risk groups, SEATTLE, Nov. ... today that it will commit $50 million to ... organizations to expand HIV,prevention efforts in China. The ... those most vulnerable to infection, including,injection drug users, ...
... In either an,inadvertent omission or a betrayal ... Nunez lacks any mention of the tax,credits he ... that is otherwise unaffordable, said the Foundation for ... concern that though the funding source for,expansion of ...
... Board of Regents of ACS publishes commentary in JAMA, ... Surgeons added,its voice to a commentary on the surgeon ... of the American Medical Association (JAMA). The,article, "The Impending ... Fischer, MD, FACS, chair of the College,s Board of ...
... Nexus CGH with Illumina,s BeadStudio Software -, ... BioDiscovery announced,today that it joined Illumina Connect, ... downstream analysis of microarray data. After,collaborating with ... allows customers using both Illumina,s BeadStudio software,to ...
Other Medicine News:Health News:New Med Mal Insurance Company Medicus to Stay in Illinois 2Health News:First United Nations World Diabetes Day Unites Global Diabetes Community to Fight the Epidemic 2Health News:First United Nations World Diabetes Day Unites Global Diabetes Community to Fight the Epidemic 3Health News:First United Nations World Diabetes Day Unites Global Diabetes Community to Fight the Epidemic 4Health News:Gates Foundation Commits to Expansion of HIV Prevention in China 2Health News:Gates Foundation Commits to Expansion of HIV Prevention in China 3Health News:Nunez Health Reform Bill Establishes Mandatory Purchase Without Linking to Subsidies for Middle Class and Poor 2Health News:Nunez Health Reform Bill Establishes Mandatory Purchase Without Linking to Subsidies for Middle Class and Poor 3Health News:Nunez Health Reform Bill Establishes Mandatory Purchase Without Linking to Subsidies for Middle Class and Poor 4Health News:Nunez Health Reform Bill Establishes Mandatory Purchase Without Linking to Subsidies for Middle Class and Poor 5Health News:Nunez Health Reform Bill Establishes Mandatory Purchase Without Linking to Subsidies for Middle Class and Poor 6Health News:Nunez Health Reform Bill Establishes Mandatory Purchase Without Linking to Subsidies for Middle Class and Poor 7Health News:American College of Surgeons Comments on JAMA Article on Surgeon Shortage 2Health News:BioDiscovery Joins Illumina Connect Bioinformatics Program 2New Med Mal Insurance Company Medicus to Stay in IllinoisFirst United Nations World Diabetes Day Unites Global Diabetes Community to Fight the EpidemicGates Foundation Commits to Expansion of HIV Prevention in ChinaNunez Health Reform Bill Establishes Mandatory Purchase Without Linking to Subsidies for Middle Class and PoorAmerican College of Surgeons Comments on JAMA Article on Surgeon ShortageBioDiscovery Joins Illumina Connect Bioinformatics Program
(Date:5/23/2012)... 2012 QRxPharma Limited (ASX: QRX and OTCQX: ... Trademark Office (USPTO) issued the Company U.S. Patent No. ... covers a method of treatment of pain comprising the ... compositions of MoxDuo IR (Immediate Release) for the ... (Controlled Release) for the treatment of chronic pain. ...
(Date:5/23/2012)... Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today announced ... phase 2 clinical trial, T reatment with ... E fficacy T rial (TARGET-NTM), ... non-tuberculous mycobacterial (NTM) lung disease. There ... NTM treatment recommendations, and no new drugs have been ...
(Date:5/23/2012)... 2012 Isis Pharmaceuticals, Inc. (NASDAQ: ... presented at EAS 2012When:Friday, June 1st at 12:00 ... Internet. Simply log onto our Web site listed ... the live event, a replay of the webcast ... www.isispharm.com . ABOUT ISIS ...
Breaking Medicine Technology:QRxPharma Granted Additional US Patent on MoxDuo® 2QRxPharma Granted Additional US Patent on MoxDuo® 3Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease 2Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease 3Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease 4Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease 5TPI Receives Approval for High Tech Enterprise Status 23168 1TPI Receives Approval for High Tech Enterprise Status 23168 2FDA to Review Potential New Use of XGEVA AE 28Denosumab 29 at Oncologic Drugs Advisory Committee Meeting 23167 1FDA to Review Potential New Use of XGEVA AE 28Denosumab 29 at Oncologic Drugs Advisory Committee Meeting 23167 2FDA to Review Potential New Use of XGEVA AE 28Denosumab 29 at Oncologic Drugs Advisory Committee Meeting 23167 3FDA to Review Potential New Use of XGEVA AE 28Denosumab 29 at Oncologic Drugs Advisory Committee Meeting 23167 4FDA to Review Potential New Use of XGEVA AE 28Denosumab 29 at Oncologic Drugs Advisory Committee Meeting 23167 5FDA to Review Potential New Use of XGEVA AE 28Denosumab 29 at Oncologic Drugs Advisory Committee Meeting 23167 6FDA to Review Potential New Use of XGEVA AE 28Denosumab 29 at Oncologic Drugs Advisory Committee Meeting 23167 7FDA to Review Potential New Use of XGEVA AE 28Denosumab 29 at Oncologic Drugs Advisory Committee Meeting 23167 8Risk Factors for Vision Loss After Spine Surgery Identified 88223 1Risk Factors for Vision Loss After Spine Surgery Identified 88223 2[0] QRxPharma Granted Additional US Patent on MoxDuo®[0] Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease[0] Webcast Alert: Isis Pharmaceuticals Hosts Dr. Sotirios Tsimikas to Review KYNAMRO™ data Presented at the European Atherosclerosis Society 2012 Meeting
... 11 Premier Research Group Limited, the international clinical ... expanded their medical device operations to include full coverage ... has been offering clinical trials services in Europe since ... medical device trials and support services. "Our clients have ...
... ALTOS, Calif., March 11 InteKrin Therapeutics, Inc., a ... obesity, today announced it has completed enrollment of a ... non-TZD selective modulator of PPAR gamma (SPPARM) for the ... a 24 week, high dose active comparator (45mg Actos(R)) ...
Other Medicine Technology:Premier Research Expands its Medical Device Operations to the United States 2InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study 2Inquire...
... four different Series II Power Supplies. ... and the EPS-6000-II. These high-voltage power ... and constant power operating modes, with ... milliamps maximum current/300 watts maximum power ...
... The PowerPac Universal power supply, 100-120 and ... 0.1-3 A, and 1-500 W. The two-line, ... screen and monitoring of run progress. Built-in ... This unit contains a built-in switch when ...
... power supply, 100-120 and 220-240 ... V, 4-400 mA, and 75 ... built-in switch when using either ... power cord. Power cord and ...
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |